Friday 26 Apr 2024
By
main news image

KUALA LUMPUR (Sept 22): Bintai Kinden Corp Bhd jumped in the morning trading session today after entering into a licensing agreement with US-based firm Generex Biotechnology Corp for Covid-19 vaccine compounds in Malaysia.

As at 10.23am, shares in Bintai Kinden — the most active on Bursa Malaysia so far today — had jumped as much as 18.11% or 11.5 sen to 75 sen, bringing the stock's market capitalisation to RM218.64 million. 

Some 133.01 million shares changed hands, exceeding its 200-day average volume of 10.93 million.

Yesterday, the group announced that it will hold the exclusive licence in Malaysia when it comes to commercialisation and development of compounds and research information relating to Covid-19 vaccines.

Besides, the group also noted that it will have the right of first refusal when it comes to development and commercialisation of vaccine compounds and research information in New Zealand, Australia and global halal markets.

Edited BySurin Murugiah
      Print
      Text Size
      Share